167
Participants
Start Date
September 30, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
March 31, 2016
DFN-02
Active Experimental Drug
Upstate Clinical Research Associates LLC, Williamsville
Dent Neurologic Institute, Amherst
Thomas Jefferson University, Philadelphia
Carman Research, Smyrna
Florida Clinical Research Center, LLC, Maitland
Neurology Clinical Research, Inc, Sunrise
Florida Clinical Research Center, Bradenton
Community Research, Cincinnati
Michigan Head Pain & Neurological Institute, Ann Arbor
Clinvest/A Division of Banyan Group, Inc., Springfield
Future Search Trials of Dallas, LP, Dallas
Protenium Clinical Research, LLC, Bedford
FutureSearch Trials of Neurology, LP, Austin
Arizona Research Center, Phoenix
Albuquerque Clinical Trials, Inc., Albuquerque
California Medical Clinic for Headache, Santa Monica
Collaborative Neuroscience Network, LLC, Long Beach
Breakthrough Clinical Trials, San Bernardino
San Francisco Clinical Research Center, San Francisco
Stanford University Medical Center, Stanford
Northern California Clinical Research Center, Redding
Associated Neurologists of Southern CT, P.C., Fairfield
Novex Clinical Research, New Bedford
MedVadis Research Corporation, Watertown
Lead Sponsor
Dr. Reddy's Laboratories Limited
INDUSTRY